Neither protein kinase C nor adenylate cyclase are altered in the striatum from subjects with schizophrenia

Schizophrenia Research

Volumn 22, Issue 2, 1996, Pages 159-164

  Opeskin, Kenneth ^a,b   Dean, Brian ^a   Pavey, Geoffrey ^a   Hill, Christine ^a   Keks, Nicholas ^a,c   Copolov, David ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b Victorian Inst of Forensic Pathol   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

3H forskolin binding; 3H pdbu binding; adenylate cyclase; protein kinase c; schizophrenia

Indexed keywords

ADENYLATE CYCLASE; DOPAMINE RECEPTOR; PROTEIN KINASE C;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SCHIZOPHRENIA;

ADENYLATE CYCLASE; ADULT; AGED; AUTORADIOGRAPHY; CORPUS STRIATUM; HUMANS; MALE; MIDDLE AGED; PROTEIN KINASE C; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0030588941     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(96)00065-5     Document Type: Article

References (17)

1. American Psychiatric Association. (1987) Diagnostic and Statistical Manual of Mental Disorder (3rd edn., revised), The American Psychiatric Press, Washington, DC.
2. Aubach, G. (1982) Polypeptide and amine hormone regulation of adenylate cyclase. Annu. Rev. Physiol. 44, 653-666.
3. Carenzi, A., Gillin, J.C., Guidotti, A., Schwartz, M.A., Trabucchi, M. and Wyatt, R.J. (1975) Dopamine sensitive adenylate cyclase in human caudate nucleus - A study in control subjects and schizophrenic patients. Arch. Gen. Psychiatry 32, 1056-1059.
4. 2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes. J. Neurochem. 63, 169-176.
5. 3H]phorbol 12,13-dibutyrate binding to protein kinase C in Alzheimers disease. J. Neurochem. 56, 1121-1129.
6. Journot, L., Homburger, V., Pantaloni, C., Priam, M., Bockaert, J. and Enjalbert, A. (1987) An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells. J. Biol. Chem. 262, 15106-15110.
7. Kaiya, H. et al. (1992) Second messenger imbalance hypothesis of schizophrenia. Prostaglandins Leukotrienes Essential Fatty Acids 46, 33-38.
8. 1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and inhibitory effects on aggregation. Psychopharmacol. Bull. 26, 381-384.
9. Kerwin, R.W. and Beats, B.C. (1990) Increased forskolin binding in the left parahippocampal gyrus and CA1 region in post mortem schizophrenic brain determined by quantitative autoradiography. Neurosci. Lett. 118, 164-168.
10. 3H]emonapride binding in the schizophrenic brain. Proc. Aust. Neursci. Soc. 6, 64 (Abstract)
11. 1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics. Science 221, 1304-1307.
12. oa immunoreactivities in left temporal cortices from patients with schizophrenia. Brain Res. 615, 41-49.
13. 3H-cAMP accumulation in platelets from schizophrenics. Life Sci. 23, 1989-1996.
14. Schramm, M. and Selinger, Z. (1984) Message transmission: receptor controlled adenylate cyclase system. Science 225, 1350-1356.
15. Seeman, P. and Niznik, H.B. (1990) Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J. 4, 2737-2744.
16. Seeman, P., Bzowej, N.H., Guan, H., Bergeron, C., Reynolds, G.P., Bird, E.D., Riederer, P., Jellinger, K. and Toutellotte, W.W. (1987) Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's Diseases. Neuropsychopharmacology 1, 5-15.
17. Simmonds, S. and Strange, P. (1985) Inhibition of inositol breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cells. Neurosci. Lett. 60, 267-272.